A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors

Administered By

Awarded By

Contributors

Start/End

  • October 9, 2018 - July 31, 2021